![]() |
市場調查報告書
商品編碼
1700083
2032 年初乳市場預測:按來源、性質、形態、分銷管道、應用和地區分類的全球分析Colostrum Market Forecasts to 2032 - Global Analysis By Source (Cow, Buffalo, Goat and Sheep), Nature (Conventional and Organic), Form, Distribution Channel, Application and By Geography |
根據 Stratistics MRC 的數據,全球初乳市場預計在 2025 年達到 38 億美元,到 2032 年將達到 68 億美元,預測期內的複合年成長率為 8.7%。
哺乳動物出生後立即分泌的第一滴乳汁稱為初乳。初乳含有豐富的蛋白質、抗體和其他必需營養素,提供寶寶生長因子和重要的免疫力。這種營養豐富的淡黃色液體有助於消化器官系統的發育並保護寶寶感染疾病。初乳,也被稱為“液體黃金”,對於健康免疫系統的早期發育和維持至關重要。
根據國際酪農聯合會(IDF)的數據,2019年全球牛奶產量達8.81億噸,全球有超過60億人定期食用牛奶和其他乳製品。
提高對健康益處的認知
免疫球蛋白和生長因子等生物活性成分的科學檢驗不斷增加,增強了它們在膳食補充劑、運動營養和嬰兒奶粉領域的需求。此外,疫情後預防性醫療保健的趨勢也推動其採用。強調其在對抗感染疾病和過敏方面的作用的行銷宣傳活動進一步推動了成長,尤其是在注重健康的人群中。這種意識正在推動產品創新並擴大機能性食品和膳食補充劑的應用。
限量和季節性供應
初乳的採集需要在產犢後精確計時,因此產量僅限於特定時期。此外,道德的收穫方法和嚴格的品質標準限制了大規模商業化。酪農集中在北美和歐洲等地區,加劇了供應鏈瓶頸,並推高了成本。這些因素帶來了挑戰,尤其是在滿足全球對優質和有機乳製品日益成長的需求方面。季節性波動也會導致價格波動,影響價格敏感地區的負擔能力和市場滲透率。
對有機和天然產品的需求不斷增加
消費者越來越重視潔淨標示、非基因改造、無激素的補充劑,這促使初乳生產商採用永續和道德的採購方式。美國農業部有機認證和草飼認證等增加了產品的吸引力。此外,電子商務平台的擴張使得利基市場更容易進入。低溫加工方面的創新可以保持生物活性的完整性,這更符合天然產品的趨勢,並且可以在機能性食品和嬰兒營養等競爭市場中實現差異化。
道德和動物福利問題
關於初乳收集方法的道德問題,特別是早期將牛與牛分開,會帶來聲譽風險。動物福利法規和活動可能會導致合規要求的增加和生產成本的增加。集約化酪農的負面聲譽可能會疏遠有道德意識的消費者,並推動對植物來源替代品的需求。此外,在歐洲和北美等地區,監管審查可能會要求採購透明度,要求供應商在盈利和道德規範之間取得平衡。
由於勞動力短缺和物流限制,COVID-19 疫情最初擾亂了初乳供應鏈。然而,消費者對增強免疫力產品的興趣日益濃厚,加速了需求,尤其是對膳食補充劑的需求。由於實體零售受到限制,網路銷售激增。疫情過後,對預防性醫療保健的持續關注繼續推動成長,但通膨壓力和原物料成本帶來挑戰。製造商正在投資數位行銷和多樣化採購,以減輕未來的干擾。
預計牛市場在預測期內將佔最大佔有率
由於牛具有高免疫球蛋白濃度,廣泛用於補充劑、嬰兒奶粉和飼料,因此預計牛部分將在預測期內佔據最大的市場佔有率。它與大規模酪農的兼容性以及檢驗其健康益處的完善研究確保了其市場領先地位。此外,北美和歐洲強大的乳製品產業確保了穩定的供應。噴霧乾燥和粉末狀創新進一步增加了從運動營養到醫療治療等各種應用的可近性。
預計在預測期內,液體部分將以最高的複合年成長率成長。
由於液體飲料的便利性、生物利用度和即飲形式的適用性,預計在預測期內將出現最高的成長率。這一趨勢是由對機能飲料和兒科營養產品日益成長的需求所推動的,尤其是在新興市場。此外,保存技術的進步延長了保存期限,同時又不損害營養完整性。由於其與益生菌等其他健康成分的多功能結合,這一領域將在膳食補充劑和臨床營養領域呈現指數級成長。
在預測期內,北美預計將佔據最大的市場佔有率,這得益於其較高的健康意識、強大的研發投入以及完善的膳食補充劑行業。美國擁有密集的酪農網路和對初乳產品的監管支持的優勢。對增強免疫力的補充劑和運動營養的需求不斷成長,加上優質化趨勢,正在支撐市場的成長。製造商和醫療保健提供者之間的策略聯盟進一步加強了該地區的地位。
在預測期內,由於中產階級的擴大、都市化和可支配收入的增加,預計亞太地區將呈現最高的複合年成長率。中國和印度等國家對兒科營養和機能性食品的需求正在蓬勃發展。政府為促進母嬰健康而採取的舉措,以及人們對初乳益處的認知不斷提高,正在推動初乳的普及。此外,電子商務的擴張和全球品牌進入尚未開發的市場將推動該地區的繁榮,而這得益於疫情後向預防性醫療保健的轉變。
According to Stratistics MRC, the Global Colostrum Market is accounted for $3.8 billion in 2025 and is expected to reach $6.8 billion by 2032 growing at a CAGR of 8.7% during the forecast period. The first type of milk that mammals generate right after birth is called colostrum. It is abundant in proteins, antibodies, and other necessary nutrients, giving babies growth factors and critical immunity. This yellowish fluid, rich in nutrients, aids in the development of the digestive system and guards against infections. Colostrum, sometimes referred to as "liquid gold," is essential for the development of the immune system early on and for general health.
According to the International Dairy Federation (IDF), global milk production reached 881 million tonnes in 2019, with over 6 billion people worldwide regularly consuming milk or other dairy products.
Growing awareness of health benefits
Increased scientific validation of its bioactive components, such as immunoglobulins and growth factors, has bolstered demand across nutraceuticals, sports nutrition, and infant formula sectors. Additionally, preventive healthcare trends post-pandemic have amplified its adoption. Marketing campaigns highlighting its role in combating infections and allergies further propel growth, particularly among health-conscious demographics. This awareness is driving product innovation and expanding applications in functional foods and dietary supplements.
Limited availability and seasonal supply
Harvesting colostrum requires precise timing post-calving, restricting production to specific periods. Moreover, ethical collection practices and stringent quality standards limit large-scale commercialization. Geographic concentration of dairy farms in regions like North America and Europe exacerbates supply chain bottlenecks, raising costs. These factors challenge manufacturers in meeting rising global demand, particularly for premium and organic variants. Seasonal fluctuations also lead to price volatility, impacting affordability and market penetration in price-sensitive regions.
Growing demand for organic and natural products
Consumers increasingly prioritize clean-label, non-GMO, and hormone-free supplements, driving colostrum producers to adopt sustainable and ethical sourcing practices. Certifications such as USDA Organic and grass-fed claims enhance product appeal. Moreover, the expansion of e-commerce platforms facilitates access to niche markets. Innovations in cold-processing techniques to retain bioactive integrity further align with natural product trends, enabling differentiation in competitive markets like functional foods and infant nutrition.
Ethical and animal welfare concerns
Ethical concerns regarding colostrum harvesting practices, particularly early separation of calves from cows, pose reputational risks. Animal welfare regulations and activism could lead to stricter compliance requirements, increasing production costs. Negative publicity around intensive dairy farming may deter ethically conscious consumers, pushing demand toward plant-based alternatives. Additionally, regulatory scrutiny in regions like Europe and North America could mandate transparency in sourcing, challenging suppliers to balance profitability with ethical practices.
The Covid-19 pandemic initially disrupted colostrum supply chains due to labor shortages and logistics constraints. However, heightened consumer focus on immunity-boosting products accelerated demand, particularly in dietary supplements. Online sales surged as brick-and-mortar retail faced restrictions. Post-pandemic, sustained interest in preventive healthcare continues to drive growth, though inflationary pressures and raw material costs pose challenges. Manufacturers are investing in digital marketing and diversified sourcing to mitigate future disruptions
The cow segment is expected to be the largest during the forecast period
The cow segment is expected to account for the largest market share during the forecast period due to bovine colostrum's superior immunoglobulin concentration and widespread use in supplements, infant formula, and animal feed. Its compatibility with large-scale dairy farming and established research validating health benefits solidify its market leadership. Additionally, North America and Europe's robust dairy industries ensure consistent supply. Innovations in spray-dried and powdered forms further enhance accessibility, catering to diverse applications from sports nutrition to medical therapies.
The liquid segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the liquid segment is predicted to witness the highest growth rate driven by its convenience, bioavailability, and suitability for ready-to-drink formats. Rising demand for functional beverages and pediatric nutrition products, especially in emerging markets, fuels this trend. Moreover, advancements in preservation technologies extend shelf life without compromising nutrient integrity. The segment's versatility in combining with other health ingredients, such as probiotics, positions it for exponential growth in nutraceutical and clinical nutrition sectors.
During the forecast period, the North America region is expected to hold the largest market share due to high health awareness, strong R&D investments, and a well-established nutraceutical industry. The U.S. dominates with a dense network of dairy farms and regulatory support for colostrum-based products. Rising demand for immune-boosting supplements and sports nutrition, coupled with premiumization trends, sustains market growth. Strategic collaborations between manufacturers and healthcare providers further reinforce regional dominance.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR fueled by expanding middle-class populations, urbanization, and increasing disposable incomes. Countries like China and India witness surging demand for pediatric nutrition and functional foods. Government initiatives promoting maternal and child health, alongside rising awareness of colostrum's benefits, drive adoption. Additionally, e-commerce expansion and entry of global brands into untapped markets position the region for rapid growth, supported by a shift toward preventive healthcare post-pandemic.
Key players in the market
Some of the key players in Colostrum Market include NOW Foods, Cure Nutraceutical Pvt. Ltd., The Saskatoon Colostrum Company Ltd., Good Health Products Ltd, Sterling Technology, Deep Blue Health New Zealand Ltd., PanTheryx Inc., Biostrum Nutritech Pvt. Ltd., Colostrum BioTec GmbH, Biotaris B.V., Ingredia Nutritional, APS Biogroup Inc., La Belle Inc., Fonterra Co-operative Group Ltd., NIG Nutritionals Limited, Titan Biotech Ltd., Biodane Pharma A/S and Glanbia PLC.
In August 2024, NOW(R), a family-owned brand that has been empowering the healthy living community for more than 55 years, makes significant and unique additions to its vast wellness portfolio with the launch of its Omega-3 Gummy Chews supplement and E-Sport Reaction gaming performance supplement, which are available online and at select natural retailers nationwide.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.